This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Treatment of Tardive Dyskinesia With Donepezil

Stanley N. Caroff, E. Cabrina Campbell, Joan C. Havey, Kenneth A. Sullivan, Ira R. Katz, and Stephan C. Mann

Published: February 2, 2001

Article Abstract

Letter to the Editor

Sir: Tardive dyskinesia (TD) remains a significant clinical problem for which there is no uniformly effective therapy. The rationale for its treatment with cholinomimetic drugs derives from the conceptualization of TD as the result of an imbalance between cholinergic and dopaminergic systems in the basal ganglia. Unfortunately, the response of TD to treatment with acetylcholine precursors has been inconsistent. However, precursors may not increase acetylcholine activity if neurotransmitter synthesis is impaired in presynaptic neurons. In fact, Miller and Chouinard reviewed data which suggest that striatal cholinergic neurons are damaged in patients with TD.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 62

Quick Links: Side Effects-Medication , Tardive Dyskinesia

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Insights

LAI Antipsychotics in Schizophrenia: Long-term Outcomes of Early Use

Using data from the...

Read More...